NASDAQ:COOL - Polarityte Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$17.33 0.00 (0.00 %)
(As of 04/22/2019 03:55 PM ET)
Previous Close$17.33
Today's Range$17.33 - $17.33
52-Week Range$15.21 - $41.22
VolumeN/A
Average Volume679,141 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PolarityTE, Inc. engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE. The company was founded in 2004 and is headquartered in Salt Lake City, UT.

Receive COOL News and Ratings via Email

Sign-up to receive the latest news and ratings for COOL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:COOL
CUSIPN/A
Phone385-237-2279

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Polarityte (NASDAQ:COOL) Frequently Asked Questions

What is Polarityte's stock symbol?

Polarityte trades on the NASDAQ under the ticker symbol "COOL."

How were Polarityte's earnings last quarter?

Polarityte Inc (NASDAQ:COOL) released its earnings results on Wednesday, September, 12th. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.60) by $0.26. The company earned $0.42 million during the quarter. View Polarityte's Earnings History.

What price target have analysts set for COOL?

1 Wall Street analysts have issued twelve-month price objectives for Polarityte's shares. Their predictions range from $65.00 to $65.00. On average, they anticipate Polarityte's stock price to reach $65.00 in the next twelve months. This suggests a possible upside of 275.1% from the stock's current price. View Analyst Price Targets for Polarityte.

What is the consensus analysts' recommendation for Polarityte?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Polarityte.

What are Wall Street analysts saying about Polarityte stock?

Here are some recent quotes from research analysts about Polarityte stock:
  • 1. According to Zacks Investment Research, "PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE, AngioTE, MyoTE, CarteTE, AdiposeTE and NeuralTE. PolarityTE, Inc., formerly known as Majesco Entertainment Company, is headquatered in Salt lake City, Utah. " (8/27/2018)
  • 2. Cantor Fitzgerald analysts commented, "We believe that PolarityTE can revolutionize the field of regenerative medicine. We think SkinTE can achieve over $600 million revenue from the currently built out facility, with perhaps multiples of this number when adding bone, cartilage, heart and muscle products in development. $65/sh price target is derived from the combined risk-adjusted NPV of the future cash flows from the SkinTE product and an enterprise value for the follow-on product lines." (7/25/2018)

Has Polarityte been receiving favorable news coverage?

News coverage about COOL stock has trended somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Polarityte earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the immediate future.

Who are some of Polarityte's key competitors?

What other stocks do shareholders of Polarityte own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Polarityte investors own include AbbVie (ABBV), Opko Health (OPK), Arrowhead Pharmaceuticals (ARWR), Micron Technology (MU), Exelixis (EXEL), Nektar Therapeutics (NKTR), NVIDIA (NVDA), salesforce.com (CRM), Crispr Therapeutics (CRSP) and Amicus Therapeutics (FOLD).

Who are Polarityte's key executives?

Polarityte's management team includes the folowing people:
  • Denver M. Lough, Chairman, President, Chief Executive Officer & CSO
  • Edward Swanson, Chief Operating Officer & Executive Vice President
  • Paul Mann, Chief Financial Officer
  • Michael W. Neumeister, Chief Medical Officer
  • Stephen Milner, Chief Clinical Officer

How do I buy shares of Polarityte?

Shares of COOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Polarityte's stock price today?

One share of COOL stock can currently be purchased for approximately $17.33.

What is Polarityte's official website?

The official website for Polarityte is http://www.polarityte.com.

How can I contact Polarityte?

Polarityte's mailing address is 1960 S 4250 W, SALT LAKE CITY UT, 84104. The company can be reached via phone at 385-237-2279 or via email at [email protected]


MarketBeat Community Rating for Polarityte (NASDAQ COOL)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  200 (Vote Underperform)
Total Votes:  404
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe COOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/22/2019 by MarketBeat.com Staff

Featured Article: Price-Sales Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel